Millennium Financial Statements From 2010 to 2024

SDPC Stock  IDR 144.00  1.00  0.69%   
Millennium Pharmacon financial statements provide useful quarterly and yearly information to potential Millennium Pharmacon International investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Millennium Pharmacon financial statements helps investors assess Millennium Pharmacon's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Millennium Pharmacon's valuation are summarized below:
Millennium Pharmacon International does not presently have any fundamental ratios for analysis.
Check Millennium Pharmacon financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Millennium main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Millennium financial statements analysis is a perfect complement when working with Millennium Pharmacon Valuation or Volatility modules.
  
This module can also supplement various Millennium Pharmacon Technical models . Check out the analysis of Millennium Pharmacon Correlation against competitors.

Millennium Revenue Analysis

Millennium Pharmacon's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Revenue

 = 

Money Received

-

Discounts and Returns

More About Revenue | All Equity Analysis

Current Millennium Pharmacon Revenue

    
  2.99 T  
Most of Millennium Pharmacon's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Millennium Pharmacon International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition

Based on the latest financial disclosure, Millennium Pharmacon International reported 2.99 T of revenue. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The revenue for all Indonesia stocks is significantly lower than that of the firm.

Millennium Pharmacon Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Millennium Pharmacon's current stock value. Our valuation model uses many indicators to compare Millennium Pharmacon value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Millennium Pharmacon competition to find correlations between indicators driving Millennium Pharmacon's intrinsic value. More Info.
Millennium Pharmacon International is currently regarded as top stock in shares outstanding category among related companies. It is currently regarded as top stock in total asset category among related companies fabricating about  946.93  of Total Asset per Shares Outstanding. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Millennium Pharmacon by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Millennium Pharmacon's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Millennium Pharmacon's earnings, one of the primary drivers of an investment's value.

About Millennium Pharmacon Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Millennium Pharmacon income statement, its balance sheet, and the statement of cash flows. Millennium Pharmacon investors use historical funamental indicators, such as Millennium Pharmacon's revenue or net income, to determine how well the company is positioned to perform in the future. Although Millennium Pharmacon investors may use each financial statement separately, they are all related. The changes in Millennium Pharmacon's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Millennium Pharmacon's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Millennium Pharmacon Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Millennium Pharmacon. Please read more on our technical analysis and fundamental analysis pages.
PT Millennium Pharmacon International Tbk distributes and trades in prescription medicine, non-prescription medicine, food supplements, and medical devices. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Millennium Pharmacon operates under Medical Distribution classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1092 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Millennium Pharmacon in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Millennium Pharmacon's short interest history, or implied volatility extrapolated from Millennium Pharmacon options trading.

Currently Active Assets on Macroaxis

Check out the analysis of Millennium Pharmacon Correlation against competitors.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Complementary Tools for Millennium Stock analysis

When running Millennium Pharmacon's price analysis, check to measure Millennium Pharmacon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Millennium Pharmacon is operating at the current time. Most of Millennium Pharmacon's value examination focuses on studying past and present price action to predict the probability of Millennium Pharmacon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Millennium Pharmacon's price. Additionally, you may evaluate how the addition of Millennium Pharmacon to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bonds Directory
Find actively traded corporate debentures issued by US companies
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Please note, there is a significant difference between Millennium Pharmacon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Millennium Pharmacon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Millennium Pharmacon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.